Pharmacokinetic evaluation of fingolimod for the treatment of multiple sclerosis
Author:
Publisher
Informa Healthcare
Subject
Pharmacology,Toxicology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/17425255.2014.894019
Reference96 articles.
1. Clinical features and diagnosis of multiple sclerosis
2. Cortical lesion load associates with progression of disability in multiple sclerosis
3. Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis
4. ADVANCE Phase 3 Study of PEGylated Interferon Beta-1a for Relapsing Multiple Sclerosis: Patient Baseline Characteristics (P01.133)
5. Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mapping the Therapeutic Options for Multiple Sclerosis in Brazil: A Comprehensive Analysis;Sclerosis;2024-02-06
2. An update on the use of sphingosine 1-phosphate receptor modulators for the treatment of relapsing multiple sclerosis;Expert Opinion on Pharmacotherapy;2023-03-04
3. Fingolimod does not prevent syndecan-4 shedding from the endothelial glycocalyx in a cultured human umbilical vein endothelial cell model of vascular injury;Intensive Care Medicine Experimental;2022-08-18
4. A Validated HPLC-MS/MS Method for Quantification of Fingolimod and Fingolimod-Phosphate in Human Plasma: Application to Patients with Relapsing–Remitting Multiple Sclerosis;Applied Sciences;2022-06-15
5. Monomethyl Fumarate (MMF, Bafiertam) for the Treatment of Relapsing Forms of Multiple Sclerosis (MS);Neurology International;2021-05-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3